• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Fresenius Kabi launches single-needle option for extracorporeal photopheresis

April 24, 2023 By Sean Whooley

Fresenius Kabi logo updatedFresenius Kabi announced the availability of a single-needle venous access option for its Amicus extracorporeal photopheresis (ECP) system.

The company announced its availability at the 49th annual meeting of the European Society for Blood and Marrow Transplantation (EBMT).

Fresenius Kabi first launched the Amicus Blue system with online ECP in Europe in 2019 with double-needle venous access only. The new update includes new software (v6.1) for the Amicus Separator and new software (v2.1) for the Phelix photoactivation device. It also features a new, single-use disposable kit configurable for single- or double-needle venous access. The system also enables clinicians to switch between single- and double-needle access at any time during a procedure.

“We are thrilled to enable the single-needle option for the Amicus Blue ECP system, which will allow physicians to treat patients with limited venous access,” said Christian Hauer, president of Fresenius Kabi MedTech. “This builds on our Amicus Blue vision to provide a versatile, multi-procedural instrument to support patients’ individual needs.”

Amicus ECP now has CE mark for the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL). These skin manifestations of CTCL remain unresponsive to other forms of treatment.

Fresenius Kabi’s Amicus Separator also has European and U.S. approval for therapeutic plasma exchange, red blood cell exchange, mononuclear cell collection and platelet collection. The Amicus ECP System is not cleared for use in the U.S.

Filed Under: Business/Financial News, Drug-Device Combinations, Vascular Tagged With: Fresenius Kabi, freseniuskabi

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS